Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News
Xconomy
JULY 15, 2016
All eyes are on Holmes, who is scheduled to present data from the company’s technology at a medical conference on August 1. million Series A to develop a drug, licensed from Columbia University, for the brain cancer glioblastoma… Lyndra , a Cambridge startup working on oral drug delivery technology, has received $5.4
40 
Let's personalize your content